[HTML][HTML] Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection

L Papagno, CA Spina, A Marchant, M Salio… - PLoS …, 2004 - journals.plos.org
L Papagno, CA Spina, A Marchant, M Salio, N Rufer, S Little, T Dong, G Chesney, A Waters…
PLoS biology, 2004journals.plos.org
Progress in the fight against the HIV/AIDS epidemic is hindered by our failure to elucidate
the precise reasons for the onset of immunodeficiency in HIV-1 infection. Increasing
evidence suggests that elevated immune activation is associated with poor outcome in HIV-
1 pathogenesis. However, the basis of this association remains unclear. Through ex vivo
analysis of virus-specific CD8+ T-cells and the use of an in vitro model of naïve CD8+ T-cell
priming, we show that the activation level and the differentiation state of T-cells are closely …
Progress in the fight against the HIV/AIDS epidemic is hindered by our failure to elucidate the precise reasons for the onset of immunodeficiency in HIV-1 infection. Increasing evidence suggests that elevated immune activation is associated with poor outcome in HIV-1 pathogenesis. However, the basis of this association remains unclear. Through ex vivo analysis of virus-specific CD8+ T-cells and the use of an in vitro model of naïve CD8+ T-cell priming, we show that the activation level and the differentiation state of T-cells are closely related. Acute HIV-1 infection induces massive activation of CD8+ T-cells, affecting many cell populations, not only those specific for HIV-1, which results in further differentiation of these cells. HIV disease progression correlates with increased proportions of highly differentiated CD8+ T-cells, which exhibit characteristics of replicative senescence and probably indicate a decline in T-cell competence of the infected person. The differentiation of CD8+ and CD4+ T-cells towards a state of replicative senescence is a natural process. It can be driven by excessive levels of immune stimulation. This may be part of the mechanism through which HIV-1-mediated immune activation exhausts the capacity of the immune system.
PLOS